The Journal of Allergy and Clinical Immunology
Volume 122, Issue 4 , Pages 754-759.e1, October 2008

A community-based study of tobacco smoke exposure among inner-city children with asthma in Chicago

  • Rajesh Kumar, MD

      Affiliations

    • Division of Allergy, Children's Memorial Hospital, Chicago, Ill
    • Corresponding Author InformationReprint requests: Rajesh Kumar, MD, Division of Allergy and Clinical Immunology, Children's Memorial Hospital, 2300 Children's Plaza, Box 60, Chicago, IL 60614.
  • ,
  • Laura Marie Curtis, MS

      Affiliations

    • Institute for Healthcare Studies, Northwestern University Feinberg School of Medicine, Chicago, Ill
  • ,
  • Sanjay Khiani, MD

      Affiliations

    • Division of Allergy, Rush Medical School, Chicago, Ill
  • ,
  • James Moy, MD

      Affiliations

    • Division of Allergy, Rush Medical School, Chicago, Ill
  • ,
  • Madeleine U. Shalowitz, MD

      Affiliations

    • Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Ill
  • ,
  • Lisa Sharp, PhD

      Affiliations

    • Department of Family Medicine, University of Illinois at Chicago, Chicago, Ill
  • ,
  • Ramon A. Durazo-Arvizu, PhD

      Affiliations

    • Loyola University Medical Center, Chicago, Ill
  • ,
  • John Jay Shannon, MD

      Affiliations

    • John H. Stroger Jr, Hospital of Cook County, Chicago, Ill
    • These individuals are co-senior authors.
  • ,
  • Kevin B. Weiss, MD

      Affiliations

    • Institute for Healthcare Studies, Northwestern University Feinberg School of Medicine, Chicago, Ill
    • Hines VA Hospital, Chicago, Ill
    • These individuals are co-senior authors.

Received 27 January 2008; received in revised form 5 August 2008; accepted 6 August 2008.

Background

Little is known about the level of tobacco exposure and the factors that influence exposure in children with persistent asthma.

Objective

We sought to measure tobacco smoke exposure and determine factors associated with exposure in a large urban sample of asthmatic children.

Methods

This cross-sectional study is based on a community-based cohort of 482 children (8-14 years old) with persistent asthma. Caregiver and household tobacco use were reported by the caregiver. Child tobacco smoke exposure was assessed by using salivary cotinine level. Multivariate linear regression of log-transformed salivary cotinine levels were used to characterize the relationship between smoke exposure and caregiver, household, and demographic characteristics. We used a multivariate logistic model to characterize associations with caregiver smoking.

Results

Overall, 68.5% of children had tobacco smoke exposure. Compared with nonexposed children, those exposed to smoking by a caregiver or another household member had cotinine levels that were 1.68 (95% CI, 1.45-1.94) or 1.40 (95% CI, 1.22-1.62) times higher, respectively. Compared with Hispanic children, African American and white/other children had 1.55 (95% CI, 1.16-2.06) and 1.59 (95% CI, 1.18-2.14) times higher cotinine levels, respectively. Child exposure was also associated with caregiver depression symptoms (odds ratio, 1.01; 95% CI, 1.01-1.02), and higher household income was protective (odds ratio, 0.73; 95% CI, 0.56-0.95). Independent predictors of caregiver smoking included a protective effect of higher education (odds ratio, 0.35; 95% CI, 0.15-0.83) and a positive association with potential problematic drug/alcohol use (odds ratio, 2.30; 95% CI, 1.39-3.83).

Conclusions

Tobacco smoke exposure was high in this urban sample of asthmatic children. Caregiver smoking was strongly associated with child exposure and also was associated with lower socioeconomic status, non-Hispanic ethnicity, and depression symptoms.

Key words: Inner-city asthma, child, tobacco smoke exposure, cotinine

Abbreviations used: CES-D, Clinical Epidemiological Survey of Depression, CHIRAH, Chicago Initiative to Raise Asthma Health Equity, SES, Socioeconomic status

 

 Supported by National Heart, Lung, and Blood Institute grant 1UO1 HL072496-01.

 Disclosure of potential conflict of interest: R. Kumar has received research support from Versu Pharmaceuticals. L. M. Curtis has received research support from the National Institutes of Health. J. Moy has received research support from Merck. M. U. Shalowitz has received research support from the National Institute of Child Health and Development and the National Heart, Lung, and Blood Institute (NHLBI). J. J. Shannon has received research support from the NHLBI.

PII: S0091-6749(08)01496-6

doi:10.1016/j.jaci.2008.08.006

The Journal of Allergy and Clinical Immunology
Volume 122, Issue 4 , Pages 754-759.e1, October 2008